80 related articles for article (PubMed ID: 1973552)
1. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level.
McCarthy TV; Healy JM; Lehane M; Heffron JJ
Acta Anaesthesiol Belg; 1990; 41(2):107-12. PubMed ID: 1973552
[TBL] [Abstract][Full Text] [Related]
2. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.
McCarthy TV; Healy JM; Heffron JJ; Lehane M; Deufel T; Lehmann-Horn F; Farrall M; Johnson K
Nature; 1990 Feb; 343(6258):562-4. PubMed ID: 2300206
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
Healy SJ; Heffron JJ; Lehane M; Bradley DG; Johnson K; McCarthy TV
BMJ; 1991 Nov; 303(6812):1225-8. PubMed ID: 1684123
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis with calcium-induced calcium release test in Japanese malignant hyperthermia susceptible (MHS) families.
Maehara Y; Mukaida K; Hiyama E; Morio M; Kawamoto M; Yuge O
Hiroshima J Med Sci; 1999 Mar; 48(1):9-15. PubMed ID: 10213958
[TBL] [Abstract][Full Text] [Related]
5. Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree.
Moslehi R; Langlois S; Yam I; Friedman JM
Am J Med Genet; 1998 Feb; 76(1):21-7. PubMed ID: 9508059
[TBL] [Abstract][Full Text] [Related]
6. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
[TBL] [Abstract][Full Text] [Related]
7. High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families.
Iles DE; Segers B; Heytens L; Sengers RC; Wieringa B
Genomics; 1992 Nov; 14(3):749-54. PubMed ID: 1427902
[TBL] [Abstract][Full Text] [Related]
8. [Malignant hyperthermia is genetically heterogenetic. Problems in search for molecular genetic markers].
Deufel T
Fortschr Med; 1992 Jan; 110(1-2):49. PubMed ID: 1563699
[No Abstract] [Full Text] [Related]
9. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.
Deufel T; Golla A; Iles D; Meindl A; Meitinger T; Schindelhauer D; DeVries A; Pongratz D; MacLennan DH; Johnson KJ
Am J Hum Genet; 1992 Jun; 50(6):1151-61. PubMed ID: 1598899
[TBL] [Abstract][Full Text] [Related]
10. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility.
Levitt RC; Nouri N; Jedlicka AE; McKusick VA; Marks AR; Shutack JG; Fletcher JE; Rosenberg H; Meyers DA
Genomics; 1991 Nov; 11(3):543-7. PubMed ID: 1774061
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of human muscular dystrophies.
Davies KE; Forrest S; Smith T; Kenwrick S; Ball S; Dorkins H; Patterson M
Muscle Nerve; 1987; 10(3):191-9. PubMed ID: 2882417
[TBL] [Abstract][Full Text] [Related]
13. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
[TBL] [Abstract][Full Text] [Related]
14. Multipoint mapping of the central core disease locus.
Schwemmle S; Wolff K; Palmucci LM; Grimm T; Lehmann-Horn F; Hübner C; Hauser E; Iles DE; MacLennan DH; Müller CR
Genomics; 1993 Jul; 17(1):205-7. PubMed ID: 8406450
[TBL] [Abstract][Full Text] [Related]
15. Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19.
Kausch K; Lehmann-Horn F; Janka M; Wieringa B; Grimm T; Müller CR
Genomics; 1991 Jul; 10(3):765-9. PubMed ID: 1889818
[TBL] [Abstract][Full Text] [Related]
16. Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia.
Ball SP; Dorkins HR; Ellis FR; Hall JL; Halsall PJ; Hopkins PM; Mueller RF; Stewart AD
Br J Anaesth; 1993 Jan; 70(1):70-5. PubMed ID: 8431338
[TBL] [Abstract][Full Text] [Related]
17. Isolation and analysis of DNA marker revealing restriction fragment length polymorphism from X chromosome specific DNA library.
Sadakane Y
Fukuoka Igaku Zasshi; 1989 Aug; 80(8):404-15. PubMed ID: 2573569
[TBL] [Abstract][Full Text] [Related]
18. Several interacting genes influence the malignant hyperthermia phenotype.
Robinson R; Hopkins P; Carsana A; Gilly H; Halsall J; Heytens L; Islander G; Jurkat-Rott K; Müller C; Shaw MA
Hum Genet; 2003 Feb; 112(2):217-8. PubMed ID: 12522565
[TBL] [Abstract][Full Text] [Related]
19. A primary genetic linkage map of 14 polymorphic loci for the short arm of human chromosome 8.
Emi M; Fujiwara Y; Nakamura Y
Genomics; 1993 Mar; 15(3):530-4. PubMed ID: 8096828
[TBL] [Abstract][Full Text] [Related]
20. Promoter sequence, expression, and fine chromosomal mapping of the human gene (MLP) encoding the MARCKS-like protein: identification of neighboring and linked polymorphic loci for MLP and MACS and use in the evaluation of human neural tube defects.
Stumpo DJ; Eddy RL; Haley LL; Sait S; Shows TB; Lai WS; Young WS; Speer MC; Dehejia A; Polymeropoulos M; Blackshear PJ
Genomics; 1998 Apr; 49(2):253-64. PubMed ID: 9598313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
